Position in BNTX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$418,725
+$75,826 QoQ
Shares Held
4,500
+16.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#159
of 282 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $18,384,772 across 26 Biotechnology names. BNTX ranks #11 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,020 | $4,977,234 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,303 | $2,198,422 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,883 | $1,797,665 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
24,065 | $1,312,505 | |
| 5 | INSM |
INSMED Inc
|
12,070 | $1,286,903 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
16,000 | $915,520 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
7,299 | $571,292 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,052 | $564,871 |
All Filings in BNTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $418,725 | 4,500 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $342,899 | 3,858 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $25,132 | 264 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $35,897 | 364 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $41,523 | 390 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $35,513 | 390 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $38,362 | 323 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $198,810 | 2,474 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $228,226 | 2,474 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $267,438 | 2,534 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $275,293 | 2,534 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $276,840 | 2,565 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $348,048 | 2,794 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $317,414 | 2,113 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,917,049 | 14,213 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,028,803 | 13,607 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,143,604 | 6,705 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,155,987 | 12,242 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,916,898 | 10,685 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,473,874 | 11,050 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $114,649 | 1,050 | Shares | Sole | 2021-05-11 | |
| 2020-06-30 | $24,693 | 370 | Shares | Sole | 2020-07-22 | |
| No filing history on record for this holder in this stock. | ||||||